NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDZanubrutinib Brukinsa®
(80 mg hard capsules) 		Malignant disease and immunosuppression, Protein kinase inhibitors, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Zanubrutinib Zanubrutinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA1001: Zanubrutinib for treating marginal zone lymphoma after anti-CD20-based treatment
NICE TA1081: Zanubrutinib for treating relapsed or refractory mantle cell lymphoma
NICE TA833: Zanubrutinib for treating Waldenstrom’s macroglobulinaemia
NICE TA931: Zanubrutinib for treating chronic lymphocytic leukaemia
NICE TA978: Zanubrutinib with obinutuzumab for treating relapsed or refractory B-cell follicular lymphoma after 2 or more treatments (TERMINATED APPRAISAL)